Flu Rx Approved for New Use

FDA OKs Xofluza (baloxavir marboxil) for those at high risk of flu complications

(RxWiki News) The flu medication Xofluza (baloxavir marboxil) has been approved for a new use.

The US Food and Drug Administration (FDA) has expanded the use of baloxavir marboxil. In 2018, this medication was approved to treat the flu (uncomplicated) in patients 12 years of age and older.

Now, it's FDA-approved to treat patients at high risk for flu-related complications.

Although healthy people can get the flu and serious issues can occur at any age, some people face a higher risk for flu-related complications if they get the flu. High-risk groups include those older than 65 and those with diabetes, asthma or heart disease.

Flu complications may include pneumonia, bronchitis and sinus infections. Complications can result in hospitalization and even death.

Xofluza is taken by mouth as a one-time dose. Common side effects may include nausea, diarrhea, headache, bronchitis and common cold symptoms.

This medication is not to be taken with dairy products or calcium-fortified beverages. In addition, it is not to be taken with laxatives, antacids or products that contain iron, zinc, selenium, calcium or magnesium. That's because these medications, products and foods can interact with baloxavir marboxil.

Speak with your health care provider if you have any questions about the flu or how to stay healthy this winter.

Written by Anyssa Garza, PharmD, BCMAS

Citation: 
Healio, "FDA approves Xofluza for patients at high risk for flu-related complications" Medscape, "FDA Expands Xofluza Indication to People at High-Risk for Flu Complications" US Food and Drug Administration, "XOFLUZA. [Prescribing Information]. Genentech. San Francisco, CA. 2018." Centers for Disease Control and Prevention, "Key Facts About Influenza (Flu)" Centers for Disease Control and Prevention, "People at High Risk For Flu Complications" Image Courtesy of Wavebreakmedia Ltd | Dreamstime